Search for: "Lisa Nicholson "
Results 21 - 40
of 83
Sorted by Relevance
|
Sort by Date
15 Dec 2020, 8:50 am
The panel, put together by Nicholson Price, will take place at AALS on January 8th at 11AM EST, and will feature myself (Camilla Hrdy), Dan Brean, Marc Blitz, Deven Desai, and Victoria Sutton. [read post]
14 May 2007, 10:49 pm
Hurley said Nicholson was suspended "pending investigation of prior allegations of mistreatment of youth. [read post]
5 Nov 2010, 9:33 am
" Arguing for a death sentence, prosecutor Gary Nicholson told the jury that "if there ever was a case where the facts and the law require such a penalty, it is this case. [read post]
10 Sep 2020, 6:23 pm
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
2 Jul 2020, 10:15 am
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
21 Aug 2011, 5:58 am
Scott Nicholson at Syracuse. [read post]
31 May 2016, 4:44 pm
Sachs follows in the footsteps of IP scholars like Amy Kapczynski, along with Rebecca Eisenberg, Nicholson Price, Arti Rai, and Ben Roin–and draws on plentiful literature in the health law field that IP scholars may never see. [read post]
12 Nov 2007, 10:32 pm
[18] Lisa R. [read post]
11 Jun 2020, 2:30 pm
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceOver the past two weeks, the United States—already hit hard by the COVID-19 pandemic—has reckoned with another public health crisis: police violence against Black Americans. [read post]
12 May 2020, 7:49 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceThe antiviral drug remdesivir, developed by California-based biopharmaceutical company Gilead Sciences in collaboration with government scientists, has emerged as the new standard of care for COVID-19 patients. [read post]
3 Jun 2021, 8:56 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsRecently, Pfizer and BioNTech and Moderna announced that they are seeking full FDA approval for their mRNA COVID-19 vaccines—filing, in FDA parlance, a Biologics License Application (BLA). [read post]
18 Feb 2021, 10:24 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceIn our last post, we introduced some of the clinical evidence supporting the use of therapeutic antibodies against COVID-19—including Regeneron’s casirivimab and imdevimab and Eli Lilly’s bamlanivimab—and analyzed the existing problems in the distribution and administration of those therapies. [read post]
29 Jan 2021, 10:26 am
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
30 Jul 2020, 3:39 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
21 Nov 2020, 7:04 am
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
12 Oct 2020, 11:52 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsA recent STAT News report found that Operation Warp Speed—the government’s Manhattan Project-style effort to quickly develop a COVID-19 vaccine—has substantial military involvement. [read post]
7 Apr 2020, 7:34 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowThe escalating pandemic has caused devastating shortages not only of ventilators and personal protective equipment like masks, but also of essential medicines needed to treat COVID-19 patients. [read post]
27 Apr 2020, 1:27 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowHealth systems worldwide are facing shortages of crucial medical supplies, including personal protective equipment (PPE), diagnostic testing components including kits and nasal swabs, and even ventilators or ventilator parts. [read post]
How is regulatory policy influencing the development and marketing of antibody testing for COVID-19?
4 May 2020, 12:56 pm
By Nicholson Price, Rachel Sachs, Jacob Sherkow, and Lisa Larrimore OuelletteOver the last few weeks, dozens of companies have begun marketing tests intended to determine whether someone has antibodies directed to SARS-CoV-2, the virus that causes COVID-19. [read post]
18 Dec 2020, 6:37 pm
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsThe past two weeks have been full of exciting COVID-19 vaccine news, including the FDA’s emergency use authorizations (EUAs) for the Pfizer–BioNTech and Moderna vaccines and the nationwide rollout of Pfizer’s vaccine. [read post]
